Search Results

I’m happy to share that I’m starting a new position as Scientific co-founder LASEREDD Therapeutics" Ross

Ines Liebscher, Ross Cheloha and Silvio Gutkind.

Canonical chemokine receptors as scavenging “decoys” Shivani Sachdev, Brendan Creemer, Thomas Gardella, and Ross Cheloha for their work on Highly biased agonism for GPCR ligands via nanobody tethering Elk Kossatz,

Ross Cheloha Dr. GPCR Podcast << Back to podcast list Dr. Ross Cheloha About this episode Dr. Ross Cheloha is an Investigator at the National Institutes of Health in the Laboratory of Bioorganic Ross and I chatted about his work and transition to an independent investigator; join me to learn more Cheloha’s work. Dr. Ross Cheloha on the web NIDDK Cheloha Lab Google Scholar LinkedIn Twitter ResearchGate Dr.

Ep 84 with Rosie Dawaliby Dr. GPCR Podcast << Back to podcast list Dr. Rosie Dawaliby About Dr. Rosie Dawaliby "I’m an expert in early-stage drug discovery, targeting membrane proteins, especially Rosie Dawaliby on the web LinkedIn Dr.

Pathophysiology Date & Time Friday, November 3rd / 9:45 AM Abstract Coming Soon Authors and Affiliations Gross About Joshua Gross "I am a neuropharmacologist interested in exploiting GPCR biased signaling to design pharmacotherapies that improve efficacy and minimize side effects for diet-induced metabolic diseases. " Josh Gross